Intravenous Buprenorphine Micro-dosing Induction in a Patient on Methadone Treatment: A Case Report.  Crane K, Snead J, Stanley R, Avery J, Ghosh SM, Mints G.  Psychosomatics. 2020 Jul 25:S0033-3182(20)30213-9. doi: 10.1016/j.psym.2020.0…

Microdosing and standard-dosing take-home buprenorphine from the emergency department: A feasibility study.  Moe J, Badke K, Pratt M, Cho RY, Azar P, Flemming H, Sutherland KA, Harvey B, Gurney L, Lockington J, Brasher P, Gill S, Garrod E, Bat…

Effectiveness of incentivised adherence and abstinence monitoring in buprenorphine maintenance: a pragmatic, randomised controlled trial.  Elarabi, H. F., Shawky, M., Mustafa, N., Radwan, D., Elarasheed, A., Yousif Ali, A., Osman, M., Kashmar…

Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France.  Mezaache, S., Carrieri, P., Briand-Madrid, L. et al  Harm Reduct J 18, 11…

Addiction Recovery Among Opioid-Dependent Patients Treated With Injectable Subcutaneous Depot Buprenorphine: Study Protocol of a Non-randomized Prospective Observational Study (ARIDE).  Schulte B, Lehmann K, Schmidt CS, Rühling E, Weber B, Sch…

Buprenorphine-naloxone microdosing: Tool for opioid agonist therapy induction.  Marwah R, Coons C, Myers J, Dumont Z.  Can Fam Physician. 2020 Dec;66(12):891-894. French. doi: 10.46747/cfp.6612891. Erratum in: Can Fam Physician. 2020 Dec…